West Pharmaceutical Services Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones

2025.11.24 22:09

I'm PortAI, I can summarize articles.

West Pharmaceutical Services Inc. (WST) stock rose 1.08% to $273.99 on Monday, despite underperforming the market. The S&P 500 Index increased by 1.55% and the Dow Jones Industrial Average by 0.44%. This marks the second consecutive day of gains for WST, which remains 21.47% below its 52-week high. Competitors Abbott Laboratories, Becton Dickinson & Co., and Baxter International Inc. saw declines. Trading volume was higher than the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of West Pharmaceutical Services Inc. (WST) advanced 1.08% to $273.99 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.55% to 6,705.12 and the Dow Jones Industrial Average rising 0.44% to 46,448.27. This was the stock's second consecutive day of gains. West Pharmaceutical Services Inc. closed 21.47% below its 52-week high of $348.90, which the company achieved on January 28th. The stock outperformed some of its competitors Monday, as Abbott Laboratories (ABT) fell 0.72% to $127.19, Becton Dickinson & Co. (BDX) fell 0.91% to $190.96, and Baxter International Inc. (BAX) fell 0.71% to $18.18. Trading volume (896,020) eclipsed its 50-day average volume of 707,187. Data source: Dow Jones Market Data, FactSet. Data compiled November 24, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-24-25 1709ET